Thierry Lesimple

7PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 28, 2024
The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab vs. nivolumab in a real-world setting.

Karine Billard, Laurent Mortier, Olivier Dereure

|Feb 10, 2023
The concomitant use of proton pump inhibitors and BRAF/MEK inhibitors in metastatic melanoma.

Florence Poizeau, Frédéric Balusson, Florian Lemaitre

|Dec 14, 2022
Phase I Study of Androgen Deprivation Therapy in Combination with Anti-PD-1 in Melanoma Patients Pretreated with Anti-PD-1.

Caroline Robert, Céleste Lebbé, Thierry Lesimple

|Mar 07, 2022
The Association Between Antibiotic Use and Outcome Among Metastatic Melanoma Patients Receiving Immunotherapy.

Florence Poizeau, Sandrine Kerbrat, Frédéric Balusson

|Jul 02, 2021
Tolerance and Effectiveness of Targeted Therapies in Aged Patients with Metastatic Melanoma.

Ondine Becquart, Bastien Oriano, Stéphane Dalle

Pageof 2